ArticleHeliyon2023

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients.

Tianying Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.